{"Q": 1, "answer": "no", "rationale": "No intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_12940", "batch_size": 260, "batch_pos": 15, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
